These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33824100)

  • 21. An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice.
    Olofinnade AT; Onaolapo TM; Oladimeji S; Fatoki AM; Balogun CI; Onaolapo AY; Onaolapo OJ
    Cent Nerv Syst Agents Med Chem; 2020; 20(1):13-25. PubMed ID: 31987026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson's disease.
    Gaur V; Bodhankar SL; Mohan V; Thakurdesai PA
    Pharm Biol; 2013 May; 51(5):550-7. PubMed ID: 23368940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q
    Onaolapo OJ; Odeniyi AO; Jonathan SO; Samuel MO; Amadiegwu D; Olawale A; Tiamiyu AO; Ojo FO; Yahaya HA; Ayeni OJ; Onaolapo AY
    Curr Aging Sci; 2021; 14(1):62-75. PubMed ID: 31702498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.
    Shin KS; Zhao TT; Choi HS; Hwang BY; Lee CK; Lee MK
    Brain Res; 2014 Jun; 1567():57-65. PubMed ID: 24747613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats.
    Ranpariya VL; Parmar SK; Sheth NR; Chandrashekhar VM
    Pharm Biol; 2011 Jul; 49(7):696-701. PubMed ID: 21599496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
    Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
    Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticataleptic activity of Zamzam water in chlorpromazine induced animal model of Parkinson disease.
    Riaz B; Ikram R; Sikandar B
    Pak J Pharm Sci; 2018 Mar; 31(2):393-397. PubMed ID: 29618426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
    Lebsanft HB; Kohles T; Kovar KA; Schmidt WJ
    Synapse; 2005 Mar; 55(3):148-55. PubMed ID: 15602749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
    Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
    J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Góngora-Alfaro JL; Moo-Puc RE; Villanueva-Toledo JR; Alvarez-Cervera FJ; Bata-García JL; Heredia-López FJ; Pineda JC
    Neurosci Lett; 2009 Oct; 463(3):210-4. PubMed ID: 19654037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model.
    Shalavadi MH; Chandrashekhar VM; Avinash SP; Sowmya C; Ramkishan A
    Indian J Pharmacol; 2012; 44(6):737-43. PubMed ID: 23248404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Luthra PM; Barodia SK; Raghubir R
    J Neurosci Methods; 2009 Apr; 178(2):284-90. PubMed ID: 19146880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents.
    Sonibare MA; Umukoro S; Shonibare ET
    J Nat Med; 2012 Jan; 66(1):127-32. PubMed ID: 21717088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys.
    Bonifácio MJ; Sousa F; Soares-da-Silva P
    Eur J Pharmacol; 2021 Feb; 892():173742. PubMed ID: 33220276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson's disease.
    Wu J; Zhao YM; Deng ZK
    Pharmacol Rep; 2018 Feb; 70(1):139-145. PubMed ID: 29367101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
    Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
    Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.
    Carta AR; Pinna A; Tronci E; Morelli M
    Neurology; 2003 Dec; 61(11 Suppl 6):S39-43. PubMed ID: 14663008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
    Alam M; Schmidt WJ
    Behav Brain Res; 2004 Aug; 153(2):439-46. PubMed ID: 15265640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.